SCHEMBL15022252

SCHEMBL15022252

Brc1ccc(-n2nccc2-c2ccncn2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK9 P45984 2/20 0.39
▸ MAPK10 P53779 2/20 0.39
▸ MAPK8 P45983 1/20 0.39
▸ USP8 P40818 1/20 0.35
▸ KDM5A P29375 1/20 0.35
▸ KDM4C Q9H3R0 1/20 0.35
▸ KDM5B Q9UGL1 1/20 0.35
▸ GSK3B P49841 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ NR3C2 P08235 5/20 0.32
▸ ALDH1A1 P00352 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ ATM Q13315 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ GLA P06280 1/20 0.31
▸ NFKB1 P19838 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ NFKB2 Q00653 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27309749 0.84 MAPK9 (0.48) MAPK9MAPK10MAPK8NR3C2ALDH1A1
SCHEMBL15022988 0.77 MAPK9 (0.59) MAPK9MAPK10MAPK8USP8KDM5A
SCHEMBL28179494 0.74 KDM5A (0.50) MAPK9MAPK10MAPK8USP8KDM5A
SCHEMBL15022076 0.73 MAPK9 (0.58) MAPK9MAPK10MAPK8USP8KDM5A
SCHEMBL30273511 0.70 CYP2D6 (0.51) MAPK9MAPK10MEN1KMT2AALDH1A1
SCHEMBL8566727 0.70 CYP2D6 (0.51) MAPK9MAPK10MEN1KMT2AALDH1A1
SCHEMBL27975371 0.69 MAPK9 (0.56) MAPK9MAPK10MAPK8NR3C2ALDH1A1
SCHEMBL28078259 0.69 CYP2D6 (0.50) MAPK9MAPK10MEN1KMT2AALDH1A1
SCHEMBL10038573 0.67 MDM2 (0.43) MAPK9MAPK10MAPK8USP8MEN1
SCHEMBL15574080 0.66 ALDH1A1 (0.43) MAPK9MAPK10MAPK8KDM5AKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130158031-A1 ALKYNE-BRIDGED HETERO-AROMATICS AND USES THEREOF SU ZHOU JING HONG BIOTECH CO., LTD. (CN) 2013-06-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158031-A1 ALKYNE-BRIDGED HETERO-AROMATICS AND USES THEREOF CHRNA10, ATXN10, SCN10A MAPK9 1943/4885MAPK10 61/4885MAPK8 2561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback